MAFLD or MASLD: Which better represents the prognosis of the steatotic liver population: Letter to the editor on “Evolutionary changes in metabolic dysfunction-associated steatotic liver disease and risk of hepatocellular carcinoma: A nationwide cohort study” - Ying Wang; Shengfeng Wang; Xiude Fan; Jiajun Zhao; Yongfeng Song (Clinical and Molecular Hepatology)